PK and Drug Interaction Study of Utidelone Plus Capecitabine in Patients With Advanced Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Advanced and Metastatic Breast Cancer
Interventions: DRUG: Utidelone Injection; capecitabine|DRUG: Utidelone
Sponsor: Beijing Biostar Pharmaceuticals Co., Ltd.
Collaborators: Chengdu Biostar Pharmaceuticals